GSK stock at EUR 20.59 with volume 70.2 percent below average

Published on 10/08/2026 at 16:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GSK stock costs EUR 20.59 on October 8, 2026 versus EUR 20.99, down 1.91 percent. Volume is 70.2 percent below average.

Key points in brief

GSK stock was EUR 20.59 at Lang & Schwarz on October 8, 2026, down 1.91 percent versus EUR 20.99.
Trading volume was 1,122,586 shares, 70.2 percent below the 3,768,439-share average.
The separate USD quote was USD 46.18, with a 52-week range of USD 42.85 to USD 61.70 and a P/E ratio of 14.69.
GSK's next scheduled report is the third-quarter 2026 release on October 28, 2026.

Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht — GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK (ISIN GB00BN7SWP63) was trading at EUR 20.59 at Lang & Schwarz on October 8, 2026 at 4:38 p.m. CEST, down 1.91 percent versus the prior close of EUR 20.99. The quote places the stock in a measured intraday decline while the trading volume remains well below its recent average.

Volume trails the average

Lang & Schwarz showed a bid of EUR 20.57 and an ask of EUR 20.60 at the same time. The separate finance quote for GSK stood at USD 46.18 at 2:46 p.m. UTC, down USD 0.84 or 1.79 percent from USD 47.02, so the home-currency indication pointed in the same direction without replacing the euro reference price.

Trading volume was 1,122,586 shares on October 8, 2026, against an average volume of 3,768,439 shares. That is 70.2 percent below the average, making participation the clearest market statistic alongside the daily decline.

Range leaves room on both sides

The separate USD quote carried a 52-week range of USD 42.85 to USD 61.70 as of October 8, 2026. Its P/E ratio was 14.69, while the market capitalization was USD 92.5 billion after rounding the reported USD 92,521,630,611 to one decimal billion.

The currency separation matters for German investors: the Lang & Schwarz price is an EUR reference, while the range, valuation multiple and market capitalization belong to the separate USD quote. GSK's primary listing is on the London Stock Exchange, as TradingView reported on October 6, 2026, citing the company's admission notice for ordinary shares with ISIN GB00BN7SWP63.

Comparison with peers

GSK: minus 1.8 percent, P/E 14.7, market capitalization USD 92.5 billion

AstraZeneca:

Sanofi:

Next report is October 28

GSK's next scheduled reporting date is October 28, 2026, for its third-quarter 2026 results. MarketBeat lists the release before market open and the conference call at 8:00 a.m. ET.

On October 6, 2026, GSK's regulatory notice covered the admission of 19,352 further ordinary shares, bringing the stated total to 4,316,311,662 shares. The filing also identified the London Stock Exchange Main Market and the GB00BN7SWP63 security, keeping the listing reference distinct from the euro quote.

Price remains the key marker

For German investors, the decisive reference remains the EUR 20.59 Lang & Schwarz indication and its EUR 20.99 prior close. The combination of a 1.91 percent daily decline and volume 70.2 percent below average describes a softer session without assigning a cause that the available market figures do not establish.

The further course of trading is shown by the continuously updated real-time quote of GSK stock.